{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:36:28Z","timestamp":1795026988332,"version":"4.10.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The availability of tools to accurately replicate the clinical phenotype of rare human diseases is a key step toward improved understanding of disease progression and the development of more effective therapeutics. We successfully generated the first large animal model of a rare human bone disease, hypophosphatasia (HPP) using CRISPR\/Cas9 to introduce a single point mutation in the tissue nonspecific alkaline phosphatase (TNSALP) gene (<jats:italic>ALPL<\/jats:italic>) (1077\u2009C\u2009&gt;\u2009G) in sheep. HPP is a rare inherited disorder of mineral metabolism that affects bone and tooth development, and is associated with muscle weakness. Compared to wild-type (WT) controls, HPP sheep have reduced serum alkaline phosphatase activity, decreased tail vertebral bone size, and metaphyseal flaring, consistent with the mineralization deficits observed in human HPP patients. Computed tomography revealed short roots and thin dentin in incisors, and reduced mandibular bone in HPP vs. WT sheep, accurately replicating odonto-HPP. Skeletal muscle biopsies revealed aberrant fiber size and disorganized mitochondrial cristae structure in HPP vs. WT sheep. These genetically engineered sheep accurately phenocopy human HPP and provide a novel large animal platform for the longitudinal study of HPP progression, as well as other rare human bone diseases.<\/jats:p>","DOI":"10.1038\/s41598-018-35079-y","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T14:27:49Z","timestamp":1542032869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Genetic engineering a large animal model of human hypophosphatasia in sheep"],"prefix":"10.1038","volume":"8","author":[{"given":"Diarra K.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pinz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane H.","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Falck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forrest","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Oldeschulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0893-2139","authenticated-orcid":false,"given":"Michael B.","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1449-8837","authenticated-orcid":false,"given":"Sarah H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Westhusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Suva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Gaddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"35079_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12, 233\u2013246 (2016).","journal-title":"Nat Rev Endocrinol"},{"key":"35079_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","volume":"93","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P., Wenkert, D. & Zhang, F. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center. Bone 93, 125\u2013138 (2016).","journal-title":"Bone"},{"key":"35079_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4158\/EP15890.OR","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho, P. M. et al. Adult Hypophosphatasia Treated with Teriparatide: Report of 2 Patients and Review of the Literature. Endocr Pract 22, 941\u2013950 (2016).","journal-title":"Endocr Pract"},{"key":"35079_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.4158\/EP.12.6.676","volume":"12","author":"HM Khandwala","year":"2006","unstructured":"Khandwala, H. M., Mumm, S. & Whyte, M. P. Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood. Endocr Pract 12, 676\u2013681 (2006).","journal-title":"Endocr Pract"},{"key":"35079_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0889-8529(18)30342-6","volume":"19","author":"MP Whyte","year":"1990","unstructured":"Whyte, M. P. Heritable metabolic and dysplastic bone diseases. Endocrinol Metab Clin North Am 19, 133\u2013173 (1990).","journal-title":"Endocrinol Metab Clin North Am"},{"key":"35079_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jpeds.2006.01.031","volume":"148","author":"MP Whyte","year":"2006","unstructured":"Whyte, M. P., Essmyer, K., Geimer, M. & Mumm, S. Homozygosity for TNSALP mutation 1348c> T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J Pediatr 148, 753\u2013758 (2006).","journal-title":"J Pediatr"},{"key":"35079_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jbmr.3075","volume":"32","author":"MP Whyte","year":"2017","unstructured":"Whyte, M. P. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges. J Bone Miner Res 32, 667\u2013675 (2017).","journal-title":"J Bone Miner Res"},{"key":"35079_CR8","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","volume":"14","author":"KN Fedde","year":"1999","unstructured":"Fedde, K. N. et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14, 2015\u20132026 (1999).","journal-title":"J Bone Miner Res"},{"key":"35079_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/0022034515573273","volume":"94","author":"BL Foster","year":"2015","unstructured":"Foster, B. L. et al. Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia. J Dent Res 94, 706\u2013714, https:\/\/doi.org\/10.1177\/0022034515573273 (2015).","journal-title":"J Dent Res"},{"key":"35079_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/0022034510393517","volume":"90","author":"MD McKee","year":"2011","unstructured":"McKee, M. D. et al. Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90, 470\u2013476 (2011).","journal-title":"J Dent Res"},{"key":"35079_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Millan","year":"2016","unstructured":"Millan, J. L. & Whyte, M. P. Alkaline Phosphatase and Hypophosphatasia. Calcif Tissue Int 98, 398\u2013416 (2016).","journal-title":"Calcif Tissue Int"},{"key":"35079_CR12","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/jbmr.1619","volume":"27","author":"MC Yadav","year":"2012","unstructured":"Yadav, M. C. et al. Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res 27, 1722\u20131734 (2012).","journal-title":"J Bone Miner Res"},{"key":"35079_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte, M. P. et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366, 904\u2013913 (2012).","journal-title":"N Engl J Med"},{"key":"35079_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/8756-3282(95)00113-R","volume":"16","author":"PD Delmas","year":"1995","unstructured":"Delmas, P. D. et al. The anabolic effect of human PTH (1\u201334) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate\u2013is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16, 603\u2013610 (1995).","journal-title":"Bone"},{"key":"35079_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/8756-3282(91)90031-D","volume":"12","author":"P Chavassieux","year":"1991","unstructured":"Chavassieux, P. et al. Dose effects on ewe bone remodeling of short-term sodium fluoride administration\u2013a histomorphometric and biochemical study. Bone 12, 421\u2013427 (1991).","journal-title":"Bone"},{"key":"35079_CR16","doi-asserted-by":"publisher","first-page":"277S","DOI":"10.1016\/S8756-3282(95)80121-9","volume":"16","author":"E Newman","year":"1995","unstructured":"Newman, E., Turner, A. S. & Wark, J. D. The potential of sheep for the study of osteopenia: current status and comparison with other animal models. Bone 16, 277S\u2013284S (1995).","journal-title":"Bone"},{"key":"35079_CR17","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.jbiomech.2014.03.025","volume":"47","author":"TC Kreipke","year":"2014","unstructured":"Kreipke, T. C. et al. Alterations in trabecular bone microarchitecture in the ovine spine and distal femur following ovariectomy. J Biomech 47, 1918\u20131921 (2014).","journal-title":"J Biomech"},{"key":"35079_CR18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bone.2004.04.006","volume":"35","author":"CM Les","year":"2004","unstructured":"Les, C. M. et al. Determinants of ovine compact bone viscoelastic properties: effects of architecture, mineralization, and remodeling. Bone 35, 729\u2013738 (2004).","journal-title":"Bone"},{"key":"35079_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.orthres.2004.12.001","volume":"23","author":"CM Les","year":"2005","unstructured":"Les, C. M. et al. Long-term ovariectomy decreases ovine compact bone viscoelasticity. J Orthop Res 23, 869\u2013876 (2005).","journal-title":"J Orthop Res"},{"key":"35079_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1053\/tvjl.2001.0642","volume":"163","author":"AS Turner","year":"2002","unstructured":"Turner, A. S. The sheep as a model for osteoporosis in humans. Vet J 163, 232\u2013239 (2002).","journal-title":"Vet J"},{"key":"35079_CR21","doi-asserted-by":"publisher","first-page":"e0136690","DOI":"10.1371\/journal.pone.0136690","volume":"10","author":"M Crispo","year":"2015","unstructured":"Crispo, M. et al. Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR\/Cas9 Technology and Microinjection into Zygotes. PLoS One 10, e0136690, https:\/\/doi.org\/10.1371\/journal.pone.0136690 (2015).","journal-title":"PLoS One"},{"key":"35079_CR22","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.2527\/jas.2017.1503","volume":"95","author":"R Hu","year":"2017","unstructured":"Hu, R. et al. RAPID COMMUNICATION: Generation of FGF5 knockout sheep via the CRISPR\/Cas9 system. J Anim Sci 95, 2019\u20132024, https:\/\/doi.org\/10.2527\/jas.2017.1503 (2017).","journal-title":"J Anim Sci"},{"key":"35079_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1071\/RD17068","volume":"30","author":"Y Niu","year":"2018","unstructured":"Niu, Y. et al. Efficient generation of goats with defined point mutation (I397V) in GDF9 through CRISPR\/Cas9. Reprod Fertil Dev 30, 307\u2013312, https:\/\/doi.org\/10.1071\/RD17068 (2018).","journal-title":"Reprod Fertil Dev"},{"key":"35079_CR24","doi-asserted-by":"publisher","first-page":"5S51","DOI":"10.1016\/S0929-693X(18)30014-9","volume":"24","author":"E Mornet","year":"2017","unstructured":"Mornet, E. Genetics of hypophosphatasia. Arch Pediatr 24, 5S51\u201355S56, https:\/\/doi.org\/10.1016\/S0929-693X(18)30014-9 (2017).","journal-title":"Arch Pediatr"},{"key":"35079_CR25","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.4158\/EP14083.CR","volume":"20","author":"S Ukarapong","year":"2014","unstructured":"Ukarapong, S., Ganapathy, S. S., Haidet, J. & Berkovitz, G. Childhood hypophosphatasia with homozygous mutation of ALPL. Endocr Pract 20, e198\u2013201, https:\/\/doi.org\/10.4158\/EP14083.CR (2014).","journal-title":"Endocr Pract"},{"key":"35079_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-9452(00)00366-6","volume":"160","author":"E No","year":"2000","unstructured":"No, E., Zhou, Y. & Loopstra, C. A. Sequences upstream and downstream of two xylem-specific pine genes influence their expression. Plant Sci 160, 77\u201386 (2000).","journal-title":"Plant Sci"},{"key":"35079_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0093-691X(99)00165-X","volume":"52","author":"F Gonzalez","year":"1999","unstructured":"Gonzalez, F. et al. Early pregnancy diagnosis in goats by determination of pregnancy-associated glycoprotein concentrations in plasma samples. Theriogenology 52, 717\u2013725, https:\/\/doi.org\/10.1016\/S0093-691X(99)00165-X (1999).","journal-title":"Theriogenology"},{"key":"35079_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. et al. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia. J Clin Endocrinol Metab 101, 334\u2013342 (2016).","journal-title":"J Clin Endocrinol Metab"},{"key":"35079_CR29","first-page":"891","volume":"25","author":"MM Weinreb","year":"1964","unstructured":"Weinreb, M. M. & Sharav, Y. Tooth Development in Sheep. Am J Vet Res 25, 891\u2013908 (1964).","journal-title":"Am J Vet Res"},{"key":"35079_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep30610","volume":"6","author":"AE Vincent","year":"2016","unstructured":"Vincent, A. E. et al. The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy. Sci Rep 6, 30610, https:\/\/doi.org\/10.1038\/srep30610 (2016).","journal-title":"Sci Rep"},{"key":"35079_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.tibtech.2008.02.002","volume":"26","author":"JP Scheerlinck","year":"2008","unstructured":"Scheerlinck, J. P., Snibson, K. J., Bowles, V. M. & Sutton, P. Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol 26, 259\u2013266, https:\/\/doi.org\/10.1016\/j.tibtech.2008.02.002 (2008).","journal-title":"Trends Biotechnol"},{"key":"35079_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0889-8529(18)30336-0","volume":"19","author":"PD Delmas","year":"1990","unstructured":"Delmas, P. D. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 19, 1\u201318 (1990).","journal-title":"Endocrinol Metab Clin North Am"},{"key":"35079_CR33","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/jbmr.5650081202","volume":"8","author":"P Pastoureau","year":"1993","unstructured":"Pastoureau, P., Vergnaud, P., Meunier, P. J. & Delmas, P. D. Osteopenia and bone-remodeling abnormalities in warfarin-treated lambs. J Bone Miner Res 8, 1417\u20131426 (1993).","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"35079_CR34","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1007\/BF02406132","volume":"36","author":"AM Parfitt","year":"1984","unstructured":"Parfitt, A. M. The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif Tissue Int 36(Suppl 1), S37\u201345 (1984).","journal-title":"Calcif Tissue Int"},{"key":"35079_CR35","doi-asserted-by":"publisher","first-page":"e85971","DOI":"10.1172\/jci.insight.85971","volume":"1","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight 1, e85971 (2016).","journal-title":"JCI Insight"},{"key":"35079_CR36","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1177\/0022034514529150","volume":"93","author":"BL Foster","year":"2014","unstructured":"Foster, B. L. et al. Rare bone diseases and their dental, oral, and craniofacial manifestations. J Dent Res 93, 7S\u201319S (2014).","journal-title":"J Dent Res"},{"key":"35079_CR37","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","volume":"23","author":"T Koressaar","year":"2007","unstructured":"Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289\u20131291, https:\/\/doi.org\/10.1093\/bioinformatics\/btm091 (2007).","journal-title":"Bioinformatics"},{"key":"35079_CR38","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3\u2013new capabilities and interfaces. Nucleic Acids Res 40, e115, https:\/\/doi.org\/10.1093\/nar\/gks596 (2012).","journal-title":"Nucleic Acids Res"},{"key":"35079_CR39","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1093\/nar\/gkg595","volume":"31","author":"M Zuker","year":"2003","unstructured":"Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31, 3406\u20133415 (2003).","journal-title":"Nucleic Acids Res"},{"key":"35079_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1021\/acssynbio.7b00268","volume":"7","author":"S Shao","year":"2018","unstructured":"Shao, S. et al. Multiplexed sgRNA Expression Allows Versatile Single Nonrepetitive DNA Labeling and Endogenous Gene Regulation. ACS Synth Biol 7, 176\u2013186, https:\/\/doi.org\/10.1021\/acssynbio.7b00268 (2018).","journal-title":"ACS Synth Biol"},{"key":"35079_CR41","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1210\/en.2006-0848","volume":"148","author":"DS Perrien","year":"2007","unstructured":"Perrien, D. S. et al. Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 148, 1654\u20131665, https:\/\/doi.org\/10.1210\/en.2006-0848 (2007).","journal-title":"Endocrinology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35079-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35079-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35079-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:49:15Z","timestamp":1671623355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35079-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35079"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35079-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16945"}}